Metastatic Pancreatic Cancer Clinical Trials

208 clinical trials for Metastatic Pancreatic Cancer across international registries, including 28 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer — RECRUITING · PHASE3
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer — RECRUITING · PHASE2
• Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer — RECRUITING · PHASE3
• Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients — RECRUITING · PHASE2
• Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) — RECRUITING · NA
• Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer — RECRUITING · NA
• Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety) — RECRUITING · NA
• A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer — RECRUITING · PHASE2
• First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer — RECRUITING · PHASE1
• Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel — RECRUITING · PHASE1
• Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients — RECRUITING · PHASE2
• Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients — RECRUITING · NA
• Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC — RECRUITING · PHASE1
• The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer — RECRUITING · PHASE3
• SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells — RECRUITING · PHASE1
• QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer — RECRUITING · PHASE2
• PRODIGE 61- FFCD 1702 - FUNGEMAX Randomized phase II study comparing 5FU/LV+Nal-IRI, gemcitabine+Nab-paclitaxel or a sequential regimen of 2 months 5FU/LV+Nal-IRI followed by two months of gemcitabine+Nab-paclitaxel, in metastatic pancreatic cancer — RECRUITING · PHASE3
• The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation — RECRUITING · PHASE2
• Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy — RECRUITING · PHASE1
• A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab — RECRUITING · PHASE1
• mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer — RECRUITING · PHASE1
• Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer — RECRUITING · PHASE1
• Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer — RECRUITING · PHASE2
• Liver Embolization Approaches for Tumor Management — RECRUITING
• Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy — RECRUITING · PHASE2
• Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma — RECRUITING · NA
• PRIMUS001: A study looking at two different treatments for pancreatic cancer that has spread to other parts of the body — ACTIVE_NOT_RECRUITING · PHASE2
• Phase 2 Open-Label Study of Volociximab (M200) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Cancer Not Previously Treated with Chemotherapy — COMPLETED · PHASE2
• Multicenter, International, Randomized, Double Blind, Placebo-Controlled, Study of Gemcitabine Combined with PEGPH20 Compared to Gemcitabine Combined with Placebo in Patients with Stage IV Previously Untreated Pancreatic Cancer, a Phase 1b/2 — TERMINATED · PHASE2
• Integrated Genomics and Avatar Mouse Models for Personalized Treatment of Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Efficacy of ABI-007 plus Gemcitabine or Simplified LV5FU2 as First-line Therapy in Patients with Metastatic Pancreatic Cancer. — COMPLETED · PHASE2
• PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 — WITHDRAWN · PHASE1
• A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy — ACTIVE_NOT_RECRUITING
• A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Combining anti-PD-L1 immune checkpoint inhibitor durvalumab with TLR-3 agonist rintatolimod in patients with metastatic pancreatic ductal adenocarcinoma for therapy efficacy. DURIPANC Study — TERMINATED · PHASE2
• Proglumide and Chemotherapy for Metastatic Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. — ACTIVE_NOT_RECRUITING · PHASE2
• Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• Saltikva for Metastatic Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Olaparib and durvalumab (MEDI4736) in patients with metastatic pancreatic cancer and DNA Damage Repair genes alterations — TERMINATED · PHASE2
• Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer — COMPLETED · PHASE1
• Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer — COMPLETED · PHASE1
• Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search